Key result
Timolol decreased weekly anginal attacks, nitroglycerin consumption, and prolonged exercise duration compared with placebo in 23 patients with angina pectoris.
Why the study?
Does timolol reduce the frequency of anginal episodes and improve exercise performance in patients with angina pectoris?
RCT (n=23)
Double-blind
crossover
Does timolol reduce the frequency of anginal episodes and improve exercise performance in patients with angina pectoris?
Timolol is an effective antianginal agent that reduces angina frequency and improves exercise tolerance when titrated to an optimal twice-daily dose.
Answers are grounded in this paper and cite their sources.
Supports titrated timolol for angina symptom control; reinforces beta-blocker efficacy in stable angina.
The effect of timolol vs placebo on the frequency of anginal episodes, nitroglycerin consumption and exercise performance was investigated in a double-blind, randomized, crossover study in 23 patients with angina pectoris. The optimal dose of timolol (10-30 mg twice daily) for each patient was titrated by exercise studies. Compared with placebo, timolol decreased the weekly number of anginal attacks and the weekly number of nitroglycerin tablets consumed, reduced the resting heart rate, systolic and diastolic blood pressure, and product of systolic blood pressure times heart rate, decreased the heart rate, systolic and diastolic blood pressure, and product of systolic blood pressure times heart rate at the onset of angina pectoris or marked fatigue, prolonged exercise duration, and diminished electrocardiographic evidence of myocardial ischemia. Timolol is an excellent antianginal agent when prescribed twice daily, with the optimal dose titrated by exercise studies.
No takes yet. Share an insight, caveat, or question.
Aronow et al. (1980) conducted an RCT in angina pectoris (n=23). Timolol vs. Placebo was evaluated on Frequency of anginal episodes, nitroglycerin consumption and exercise performance. Timolol decreased weekly anginal attacks, nitroglycerin consumption, and prolonged exercise duration compared with placebo in 23 patients with angina pectoris.
Synapse has enriched 10 related papers. Consider them for comparative context: